Biochemical Abnormalities in Fibromyalgia Syndrome

REFERENCES

• Yunus M, Masi AT, Calabro JJ, Miller KA, Feigenbaum SL: Primary fibro-myalgia (fibrositis): Clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 11: 151–171,1981.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Ross K, Anderson J, Russell LI: The prevalence and characteris-tics of fibromyalgia in the general population. Arthritis Rheum 36(9): S48, 1993.
   Google Scholar
• Russell IJ, Fletcher EM, Tsui J, Michalek JE: Comparisons of rheumatoid arthritis and fibrositis/fibromyalgia syndrome using functional and psychological outcome measures. Arthritis Rheum 32: S70, 1989.
   Google Scholar
• Cathey, Wolfe F, Kleinheksel SM: Functional ability and work statusin patients with fibromyalgia. Arthritis Care and Research 1: 85–98, 1988.
   Google Scholar
• Hamm C, Derman S, Russell U: Sleep parameters in fibrositis/fibromyal-gia syndrome (FS). Arthritis Rheum 32: S70,1989.
   Google Scholar
• Moldofslcy H, Scarisbrick P, England R, Smythe H: Musculoskeletal symptoms and Nsleep disturbance in patients with "fibrositis syndrome" andhealthy subjects. Psychosomatic Med 37: 341–351, 1975.
   PubMed Web of Science ®Google Scholar
• Allies TA, Khan SA, Yunus, Spiegel DA, Masi AT: Psychiatric statusof patients with primary fibromyalgia, patients with rheumatoid arthritis, and sub-jects without pain: a blind comparison of DSM-III diaiiioses. is J Ps-ychiat 148: 1721–1726, 1991.
   Google Scholar
• YunusKalyan-Raman UP, Masi AT, Aldag JC: Electron microscopicstudies of muscle biopsy in primary fibromyalgia syndrome: A controlled and blinded study. J Rheumatol 16: 97–101, 1989.
   PubMedGoogle Scholar
• Moldofsky H, Warsh JJ: Plasma tryptophan and musculoskeletal pain in nonarticular rheumatism ("fibrositis syndrome"). Pain 5: 65–71, 1978.
   PubMed Web of Science ®Google Scholar
• Harvey JA, Schlosberg AJ, Yunger LM: Behavioral correlates of serotonin depletion. Fed Proc 34: 1796–1801, 1975.
   PubMedGoogle Scholar
• Murphy RM, Zemlan FP: Differential effects of substance P on serotonin-modulated spinal nociceptive reflexes. Psychopharmacology (Berlin) 93: 118–121, 1987.
   PubMed Web of Science ®Google Scholar
• Russell U: Neurohormonal aspects of fibromyalgia syndrome. In: Rheu-matic Disease Clinics of North America. Edited by RM BennettandDL Golden-berg. W.B. Saunders, Philadelphia, 1989, pp. 149–168.
   Google Scholar
• Vaeroy H, Helle R, Forre O, Kass E, Terenius L: Elevated CSF levels of substance P and high incidence of Raynaud's phenomenon in patients with fibro-myalgia: New features for diagnosis. Pain 32: 21–26, 1988.
   PubMed Web of Science ®Google Scholar
• Russell U, Orr MD, Vipraio GA, Alboulcrek D, Michalek JE, MacKillip F, Lopez YM, Littman BH: Cerebrospinal fluid substance P is elevated in fibromyal-gia syndrome. Arthritis Rheum 36(9): S223, 1993.
   Google Scholar
• Russell U, Vaeroy H, Javors M, Nyberg F: Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 35: 550–556, 1992.
   PubMed Web of Science ®Google Scholar
• Russell U, Vipraio GA, Acworth I: Abnormalities in the central nervous system [CNS] metabolism of tryptophan [TRY] to 3-hydroxy lcynurenine [OHICY] in fibromyalgia syndrome [FS]. Arthritis Rheum 36(9): S222, 1993.
   Google Scholar
• Russell U, Michalek JE, Vipraio GA, Fletcher EM, Javors MA, Bowden CA: Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 19: 104–109, 1992.
   PubMed Web of Science ®Google Scholar
• Russell U, Vipraio GA, Lopez YM: Serum serotonin in fibromyalgia syn-drome, rheumatoid arthritis, osteoarthritis, and healthy normal controls. Arthritis Rheum 36(9): S223, 1993.
   Google Scholar
• Hrycaj P, Stratz T, Muller W: Platelet 3H-imipramine uptake receptor den-sity and serum serotonin in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 20: 1986–1987, 1993.
   PubMed Web of Science ®Google Scholar
• Aune TM, Pogue SL: Inhibition of tumor cell growth by interferon-gamma is mediated by two distinct mechanisms dependent upon oxygen tension: Induc-tion of tryptophan del. :dation and depletion of intracellular nicotinamide adenine dinucleotide. J Clin Invest 84: 863–875, 1989.
   PubMed Web of Science ®Google Scholar
• Russell U, Vi "o GA: Red cell nucleotide abnormalities in fibromyalgia syndrome.i "tis Rheum 36(9): S223, 1993.
   Google Scholar
• Stocchi V, Cucchiarini L, Canestrari F, Piacentini MP, Fornaini G: A very fast ion-pair reversed-phase HPLC method for the separation of the most signifi-cant nucleotides and their degradation products in human red bl• • • cells. Anal Biochem 167: 181–190, 1987.
   PubMed Web of Science ®Google Scholar
• Brown RR, Ozaki Y, Dana SP, Borden EC, Sondel PM, Malone DG: Im-plications of interferon-induced tryptophan catabolism in cancer, autoimrnune diseases and AIDS. Adv Exp Med Biol 294: 425–435, 1991.
   PubMedGoogle Scholar
• Ozaki Y, Borden EC, Smalley RV, Brown RR: Interferon type I and II an-tagonism: A novel regulatory mechanism of indoleamine dioxygenase induction in human peripheral blood rnonocytes and peritoneal macrophages. In: Kynure-nine and Serotonin Pathways. Edited by R Schwarcz. Plenum Press, New York, 1991, pp. 547–553.
   Google Scholar
• Brown RR, Borden EC, Sondel PM, Lee CM: Effects of interferons and interleulcin-2 on tryptophan metabolism in humans. Progr Tryptophan and Seroto-nin Res 19–26, 1986.
   Google Scholar
• Calvo CF, Chavanel G, Senik A: Substance P enhances H.,-2 expression in activated human T cells. J Immunol 148: 3498–3504, 1992.
   Google Scholar
• Rameshwar P. Gascon P, Ganea D: lnununoregulatory effects of neuropep-tides. Stimulation of interleulcin-2 production by substance P. J Neuroimmunol 37: 65–74, 1992.
   Google Scholar
• Weiss A, Imboden J, Hardy K, Manger B, Terhorst C, Stobo J: The role of the T3/antigen receptor complex in T-cell activation. Ann Rev Immunol 4: 593–619, 1986.
   PubMed Web of Science ®Google Scholar
• Lieberman AP, Pitha PM, Shin HS, Shin ML: Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Nati Acad Sci USA 86: 6348–6352, 1989.
   PubMed Web of Science ®Google Scholar
• Martin FC, Charles AC, Sanderson MJ, Merrill JE: Substance P stimulates IL-1 production by astrocytes via intracellular calcium. Brain Res 599: 13–18, 1992.
   PubMed Web of Science ®Google Scholar
• Cavagnaro J, Lewis RM: Bidirectional regulatory circuit between the im-mune and neuroendocrine systems. Year In Immunol 4: 241–252, 1989.
   PubMedGoogle Scholar
• Johnson CL, Johnson CG: Tumor necrosis factor and interleukin-1 down-regulate receptors for substance P in human astrocytoma cells. Brain Res 564: 79–85, 1991.
   PubMedGoogle Scholar
• Chonmaitree T, Baron S: Bacteria and viruses induce production of inter-feron in the cerebrospinal fluid of children with acute meningitis: A study of 57 cases and review. Rev Infect Dis 13: 1061–1065, 1991.
   PubMedGoogle Scholar
• Russell U, Michalek JE, Vipraio GA, Fletcher EM, Wall K: Serum amino acids in fibrositis/fibromyalgia syndrome. J Rheumatol 19: 158–163, 1989.
   Google Scholar